B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor α

Leukemia Research

Volumn 29, Issue 7, 2005, Pages 829-839

  Rosati, Emanuela ^a   Sabatini, Rita ^a   Tabilio, Antonio ^a   Di Ianni, Mauro ^a   Bartoli, Andrea ^a   Marconi, Pierfrancesco ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

B chronic lymphocytic leukemia; Cell lines; Cytotoxicity; IL 12; IL 2; TNF

Indexed keywords

CHROMIUM; CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 2; MESSENGER RNA; PROTEIN KINASE ZAP 70; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CELL STRAIN K 562; CELL STRAIN U937; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMIA CELL LINE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAJI CELL; SUPERNATANT;

ADP-RIBOSYL CYCLASE; AGED; ANTIGENS, CD; ANTIGENS, CD38; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOPHENOTYPING; JURKAT CELLS; LEUKEMIA, B-CELL, CHRONIC; LEUKOCYTE COUNT; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROTEIN-TYROSINE KINASES; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 20344394897     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.01.004     Document Type: Article

References (49)

1. J.R. Orlinick, and M.V. Chao TNF-related ligands and their receptors Cell Signal 10 1998 543 551
2. J.L. Flynn, M.M. Goldstein, J. Chan, K.J. Triebold, K. Pfeffer, and C.J. Lowenstein Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice Immunity 2 1995 561 572
3. K.J. Tracey, and A. Cerami Tumor necrosis factor, other cytokines and disease Annu Rev Cell Biol 9 1993 317 343
4. D.S. Pisetsky Tumor necrosis factor blockers in rheumatoid arthritis N Engl J Med 342 2000 810 811
5. H.-J. Gruss, and S.K. Dower Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas Blood 85 1995 3378 3404
6. P. Vandenabeele, W. Declerq, R. Beyaert, and W. Fiers Two tumor necrosis factor receptors: structure and function Trends Cell Biol 5 1995 392 399
7. Z.G. Liu, H. Hsu, D.V. Goeddel, and M. Karin Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappa B activation prevents cell death Cell 87 3 1996 565 576
8. C.F. Nathan Secretory products of macrophages J Clin Invest 79 1987 319 326
9. G. Pawelec, K. Schaudt, A. Rehbein, and F.W. Busch Differential secretion of tumor necrosis factor-alpha and granulocyte/macrophage colony-stimulating factors but not interferon-gamma from CD4+ compared to CD8+ human T cell clones Eur J Immunol 19 1989 197 200
10. T.J. Kipps Chronic lymphocytic leukaemia Curr Opin Hematol 4 1997 268 276
11. M.J. Keating Chronic lymphocytic leukaemia Semin Oncol 26 1999 107 114
12. C. Rozman, and E. Montserrat Chronic lymphocytic leukaemia N Engl J Med 333 1995 1052 1057
13. J.C. Reed Molecular biology of chronic lymphocytic leukemia Semin Oncol 25 1998 11 18
14. R. Foa, M. Massaia, S. Cardona, A.G. Tos, A. Bianchi, and C. Attisano Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease Blood 76 1990 393 400
15. A. Waage, and T. Espevik TNF receptors in chronic lymphocytic leukemia Leuk Lymph 13 1994 41 46
16. A. Waage, N. Liabakk, E. Lien, J. Lamvik, and T. Espevik p55 and p75 tumor necrosis factor receptors in patients with chronic lymphocytic leukemia Blood 80 1992 2577 2583
17. W. Digel, M. Stefanic, W. Schöniger, C. Buck, A. Raghavachar, and N. Frickhofen Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukaemia Blood 73 1989 1242 1246
18. F.T. Cordingley, A. Bianchi, A.V. Hoffbrand, J.E. Reittie, H.E. Heslop, and A. Vyakarnam Tumor necrosis factor as an autocrine tumor growth factor for chronic B-cell malignancies Lancet 1 1988 969 971
19. F. Adami, A. Guarini, M. Pini, F. Siviero, R. Sancetta, and M. Massaia Serum levels of tumour necrosis factor-alpha in patients with B-cell chronic lymphocytic leukaemia Eur J Cancer 30A 1994 1259 1263
20. A. Ferrajoli, M.J. Keating, T. Manshouri, F.J. Giles, A. Dey, and Z. Estrov The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia Blood 100 2002 1215 1219
21. B.D. Cheson, J.M. Bennett, M. Grever, N. Kay, M.J. Keating, and S. O'Brien National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment Blood 87 1996 4990 4997
22. J.L. Binet, M. Lepoprier, G. Dighiero, D. Charron, P. D'Athis, and G. Vaugier A clinical staging system for chronic lymphocytic leukemia: prognostic significance Cancer 40 1977 855 864
23. A.C. Chan, B.A. Irving, J.D. Fraser, and A. Weiss The zeta chain is associated with a tyrosine kinase and upon T-cell antigen receptor stimulation associates with ZAP-70, a 70-kDa tyrosine phosphoprotein Proc Natl Acad Sci USA 88 1991 9166 9170
24. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction Anal Biochem 162 1987 156 159
25. M. Grell, G. Zimmermann, D. Hulser, K. Pfizenmaier, and P. Scheurich TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways J Immunol 153 1994 1963 1972
26. M. Alvarez-Mon, J. Garcia-Suarez, A. Prieto, L. Manzano, E. Reyes, and C. Lorences Heterogeneous proliferative effect of tumor necrosis factor-alpha and lymphotoxin on mitogen activated B cells from B-chronic lymphocytic leukemia Am J Hematol 43 1993 81 85
27. L. Trentin, R. Zambello, C. Agostini, C. Enthammer, A. Cerutti, and F. Adami Expression and regulation of tumor necrosis factor, interleukin-2, and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukemia Blood 84 1994 4249 4256
28. R. Michalevicz, R. Porat, M. Vechoropoulos, S. Baron, M. Yanoov, and Z. Cycowitz Restoration of in vitro hematopoiesis in B-chronic lymphocytic leukemia by antibodies to tumor necrosis factor Leuk Res 15 1991 111 120
29. I. Tinhofer, I. Marschitz, M. Kos, T. Henn, A. Egle, and A. Villunger Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia Blood 91 1998 4273 4281
30. S. Zhao, Z. Asgary, Y. Wang, R. Goodwin, M. Andreeff, and A. Younes Functional expression of TRAIL by lymphoid and myeloid tumour cells Br J Haematol 106 1999 827 832
31. F.H. Igney, and P.H. Krammer Immune escape of tumors: apoptosis resistance and tumor counterattack J Leukoc Biol 71 2002 907 920
32. + highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma Blood 99 2002 1305 1313
33. T. Hamblin Chronic lymphocytic leukaemia: one disease or two? Ann Hematol 81 2002 299 303
34. M. Iwashima, B.A. Irving, N.S. van Oers, A.C. Chan, and A. Weiss Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases Science 263 1994 1136 1139
35. T.J. Hamblin Predicting progression - ZAP-70 in CLL N Engl J Med 351 2004 856 857
36. L.Z. Rassenti, L. Huynh, T.L. Toy, L. Chen, M.J. Keating, and J.G. Gribben ZAP-70 compared with immunoglobulin heavy chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia N Engl J Med 351 2004 893 901
37. M. Crespo, F. Bosch, N. Villamor, B. Bellosillo, D. Colomer, and M. Rozman ZAP-70 expression as a surrogate for immunoglobulin variable region mutations in chronic lymphocytic leukemia N Engl J Med 348 2003 1764 1775
38. A. Wiestner, A. Rosenwald, T.S. Barry, G. Wright, R.E. Davis, and S.E. Henrickson ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile Blood 101 2003 4944 4951
39. T.J. Hamblin, Z. Davis, A. Gardiner, D.G. Oscier, and F.K. Stevenson Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia Blood 94 1999 1848 1854
40. S. Ibrahim, M. Keating, K.A. Do, S. O'Brien, Y.O. Huh, and I. Jilani CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia Blood 98 2001 181 186
41. U. Thunberg, A. Johnson, G. Roos, I. Thörn, G. Tobin, and J. Sällström CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia Blood 97 2001 1892 1894
42. T.J. Hamblin, J.A. Orchard, A. Gardiner, D.G. Oscier, Z. Davis, and F.K. Stevenson Immunoglobulin V genes and CD38 expression in CLL Blood 95 2000 2455 [letter]
43. T.J. Hamblin, J.A. Orchard, R.E. Ibbotson, Z. Davis, P.W. Thomas, and F.K. Stevenson CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease Blood 99 2002 1023 1029
44. L.G. Larsson, M. Carlsson, M. Schena, M. Lantz, F. Caligaris-Cappio, and K. Nilsson Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells Leukemia 7 1993 226 234
45. J. Hulkkonen, J. Vilpo, L. Vilpo, and M. Hurme Diminished production of interleukin-6 in chronic lymphocytic leukaemia (B-CLL) cells from patients at advanced stages of disease. Tampere CLL Group Br J Haematol 100 1998 478 483
46. H.E. Heslop, A.C. Bianchi, F.T. Cordingley, M. Turne, W. Chandima, and C.P. De Mel Effects of interferon alpha on autocrine growth factor loops in B lymphoproliferative disorders J Exp Med 172 1990 1729 1734
47. F. Burke, D. Griffin, N. Elwood, C. Davis, G. Stamp, and A. Rohatiner The effect of cytokines on cultured mononuclear cells from patients with B cell chronic lymphocytic leukemia Hematol Oncol 11 1993 23 33
48. U. Brass, T. Tretter, F. Schneller, M. Schuler, C. Huber, and C. Peschel IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukaemia cells in vitro J Interferon Cytokine Res 19 1999 335 343
49. G. Parmiani, L. Rivoltini, G. Andreola, and M. Carrabba Cytokines in cancer therapy Immunol Lett 74 2000 41 44